Article · 4 May 2026
Short communicationPublished 5 Aug 2023
Analysis of the Therapeutic Effect of Pidotimod Assisted Fluticasone Propionate in Children with Asthma and their Immune Function
Abstract
Select any words in the title or abstract, or press this and choose a sentence.
We attempt to study the therapeutic effect of pidotimod assisted fluticasone propionate in children with asthma and the improvement of their immune function. We selected 93 asthmatic children admitted to the hospital from May 2021 to December 2022 for the trial. Divided them into experimental group (46 cases) and reference group (47 cases) by computerized numbered random number table. All children received conventional therapy; the experimental group was treated with fluticasone propionate, while the reference group was treated with pidotimod in addition to the experimental group. All children received 90 d treatment, compared both groups on the treatment effect, immune function and peripheral blood levels of interferon regulatory factor 1 and signal transducer-activated transcription factor-1 and the incidence of adverse effects before and after treatment. Experimental group possessed shorter disappearance time of all clinical symptoms shorter than reference group (all p 0.05). Pidotimod adjuvant to fluticasone propionate in children with asthma is effective and can improve their immune function and interferon regulatory factor 1 and signal transducer-activated transcription factor-1 expression levels without increasing the risk of adverse reactions, so it is worth promoting.
Subjects
Pharmaceutical SciencesAsk about this article
Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.
More from this journal
The newest in Indian Journal of Pharmaceutical Sciences.
Article · 21 Apr 2026
In silico molecular docking analysis of bioactive compounds from Kappaphycus alvarezii and Gracilaria debilis against BRCA1 protein
Article · 11 Mar 2026
Trimethoprim and Sulfamethoxazole-Loaded Nanoparticles Coated With Chitosan for Intranasal Delivery to Treat Cerebral Toxoplasmosis
Conferences in this field
Upcoming conferences in this field.
Follow
New articles from what you follow go into your email digest, once you agree to alert emails.
- JournalIndian Journal of Pharmaceutical Sciences
- SubjectPharmaceutical Sciences
- BylineArticles whose byline prints “Tingshen Jing”
- BylineArticles whose byline prints “Yanqin Liu”
- BylineArticles whose byline prints “Ying Wang”
- BylineArticles whose byline prints “Chunqiong Cai”
- BylineArticles whose byline prints “Hui Li”
- BylineArticles whose byline prints “Di Zhang”
- BylineArticles whose byline prints “Yunjuan Su”